Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease Rezurock is now approved in the EU for adults and children aged 12 years and older with chronic GVHD, providing a new...
-
Pelvic Floor Strong exercise claims, Layer Syndrome framework, and Alex Miller's three-step pelvic floor method for women over 40 outlined.
-
2026 report evaluating Hume Health Hume Body Pod accuracy claims, review of 98% DEXA details, 45+ metrics vs. leading bathroom scales.
-
Hume Health Hume Band claims evaluated — Metabolic Momentum, biological age tracking, AI longevity metrics, pricing, and what to verify in 2026.
-
Innovative Food Holdings, Inc. Reports Financial Results for Fourth Quarter and Fiscal Year 2025
-
Brain Savior explains its Brain Honey formula claims, Citicoline and Bacopa Monnieri research, and cognitive support positioning for 2026.
-
EDMONTON, Alberta, March 30, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ: SNDL, CSE: SNDL) (“SNDL” or the “Company”) announced today that Tyler Robson, President of Cannabis, has left the Company in...
-
REDWOOD CITY, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel...
-
Record revenue of $119.9 million, up 21.1% YOY Record 426 boats sold in 2025, up 33% YOYIncreased 2026 revenue guidance to $150–$155 millionSuccessfully completed IPO, strengthening balance sheet and...
-
RenovoCath® Generates $1.1 Million in 2025 Revenue in First Full Year of Commercialization Phase III TIGeR-PaC Trial on Track for Enrollment Completion by the Middle of 2026, and Final Data...